Monopar to Present at AASLD - The Liver Meeting® 2026: Phase 3 FoCus Baseline Data and ALXN1840 Molybdenum Safety Data Life Science Investing
Sionna Therapeutics to Participate in Upcoming November 2026 Investor Conferences Life Science Investing
Axsome Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update Life Science Investing
Tiziana Announces Positive Topline Results from Phase 2a INFORM-MS Trial of Intranasal Foralumab in Non-Active Secondary Progressive Multiple Sclerosis Life Science Investing
EraNova Metals Announces Non-Brokered Private Placement with Long Term Strategic Shareholders Life Science Investing
Innovotech Inc. Establishes New Banking Partnership with ATB Financial, Securing $600,000 in Credit Facilities to Support Growth Life Science Investing
Doseology Announces Management Cease Trade Order for Late Filing of Annual Audited Financial Statements Life Science Investing
PharmaTher Builds Portfolio of Personalized, 3D-Printed Peptide Products for New U.S. Peptide Pathway, Led by Colon-Targeted KPV and BPC-157 Life Science Investing
Novavax Earns $125 Million Milestone as Sanofi Launches Phase 3 Influenza-COVID-19 Combination Vaccine Trial in Europe Life Science Investing
Palvella Therapeutics to Host Third Quarter 2026 Financial Results and Corporate Update Conference Call on November 5, 2026 Life Science Investing
BriaCell and BriaPro Present Positive Preclinical Immunotherapy Data Across Four Posters at SITC 2026
